US5898891040
US5898891040
Merit Medical Systems, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.21B EUR | 4.14B EUR | 4.11B EUR | 5.24B EUR |
Enterprise Value | 5.46B EUR | 4.51B EUR | 4.45B EUR | 5.61B EUR |
Valuation Multiples | ||||
Trailing P/E | 35.89x | 28.44x | 29.51x | 53.26x |
Forward P/E | 18.91x | -- | -- | -- |
Price to Sales | 3.3x | 2.62x | 2.67x | 4.51x |
Price to Book | 3.1x | 2.46x | 2.53x | 3.31x |
EV/Revenue | 3.46x | 2.86x | 2.88x | 4.84x |
EV/EBITDA | 16.11x | 12.47x | 12.76x | 21.99x |
Price to FCF (P/FCF) | 29.94x | 20.73x | 18.91x | 27.07x |
EV/FCF | 31.41x | 22.59x | 20.45x | 29.01x |
FCF Yield | 3.34% | 4.82% | 5.29% | 3.69% |